Swedbank AB Has $88.03 Million Stock Holdings in The Cooper Companies, Inc. $COO

Key Points

• Swedbank AB increased its stake in The Cooper Companies by 18.8%, buying 170,000 shares to hold 1,074,029 shares valued at $88.03 million, or about 0.55% of the company.
• Cooper beat Q1 estimates with $1.10 EPS (vs. $1.03 expected) and revenue of roughly $1.02B (up 6.2% YoY), gave Q2 2026 EPS guidance of 4.580–4.660, and carries a consensus "Moderate Buy" analyst rating with a $90.79 price target.

Swedbank AB grew its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 18.8% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,074,029 shares of the medical device company's stock after acquiring an additional 170,000 shares during the period. Swedbank AB owned 0.55% of Cooper Companies worth $88,027,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. Mesirow Financial Investment Management Inc. increased its position in Cooper Companies by 1.3% during the third quarter. Mesirow Financial Investment Management Inc. now owns 14,017 shares of the medical device company's stock worth $961,000 after buying an additional 175 shares during the last quarter. Blue Trust Inc. lifted its position in shares of Cooper Companies by 13.9% in the fourth quarter. Blue Trust Inc. now owns 1,515 shares of the medical device company's stock worth $124,000 after buying an additional 185 shares during the last quarter. Citizens Financial Group Inc. RI lifted its position in shares of Cooper Companies by 2.7% in the third quarter. Citizens Financial Group Inc. RI now owns 7,181 shares of the medical device company's stock worth $492,000 after buying an additional 192 shares during the last quarter. Norden Group LLC boosted its stake in shares of Cooper Companies by 3.2% during the 4th quarter. Norden Group LLC now owns 6,634 shares of the medical device company's stock worth $544,000 after acquiring an additional 205 shares in the last quarter. Finally, 4WEALTH Advisors Inc. increased its holdings in shares of Cooper Companies by 4.9% during the 4th quarter. 4WEALTH Advisors Inc. now owns 4,439 shares of the medical device company's stock valued at $364,000 after acquiring an additional 206 shares during the last quarter. Institutional investors own 24.39% of the company's stock.

Cooper Companies Price Performance

NASDAQ COO opened at $61.12 on Thursday. The stock has a 50-day simple moving average of $71.63 and a 200 day simple moving average of $76.16. The Cooper Companies, Inc. has a twelve month low of $60.00 and a twelve month high of $89.83. The stock has a market capitalization of $11.93 billion, a PE ratio of 30.26, a P/E/G ratio of 1.58 and a beta of 0.89. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.79 and a current ratio of 1.34.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, topping the consensus estimate of $1.03 by $0.07. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The company had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.02 billion. During the same period in the previous year, the business posted $0.92 EPS. The company's revenue for the quarter was up 6.2% on a year-over-year basis. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. Research analysts anticipate that The Cooper Companies, Inc. will post 4.62 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on COO shares. Wall Street Zen raised Cooper Companies from a "hold" rating to a "buy" rating in a research note on Saturday, February 28th. William Blair raised Cooper Companies to a "strong-buy" rating in a research report on Friday, January 30th. Citigroup lowered their price target on Cooper Companies from $88.00 to $87.00 and set a "neutral" rating on the stock in a report on Friday, March 6th. Needham & Company LLC boosted their price objective on shares of Cooper Companies from $99.00 to $101.00 and gave the stock a "buy" rating in a research note on Friday, March 6th. Finally, The Goldman Sachs Group reaffirmed a "sell" rating and set a $73.00 price objective on shares of Cooper Companies in a report on Friday, January 9th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $90.79.

Cooper Companies Company Profile

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.